Sprout Social (NASDAQ:SPT – Free Report) had its price target decreased by Piper Sandler from $29.00 to $27.00 in a research ...

Fintel reports that on February 28, 2025, Piper Sandler downgraded their outlook for Teleflex (NYSE:TFX) from Overweight to ...

Fintel reports that on February 28, 2025, Piper Sandler initiated coverage of Avalo Therapeutics (NasdaqCM:AVTX) with a ...

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Kymera Therapeutics (KYMR – Research Report) today and set a price target of ...

Piper Sandler lowered the firm’s price target on Dyne Therapeutics (DYN) to $48 from $53 following ATM dilution, while keeping an Overweight ...

Looking at more recent history, Kantrowitz noted that every correction from the late 1990s until 2018 "were all growth-driven market corrections." The two since 2022 have been rates-driven selloffs, ...

The only negative coming out of Nvidia's earnings? Expectations for a 71% adjusted gross margin this quarter as the company continues ahead with its Blackwell ramp, according to Piper Sandler analyst ...

Nvidia Corp.'s stock still looks good to many Wall Street analysts ahead of the artificial-intelligence chip maker's earnings Wednesday, even though the company isn't expected to report the same level ...

Nvidia (NASDAQ:NVDA) is once again at the center of Wall Street's attention as analysts set the stage for another strong ...

Nvidia (NASDAQ:NVDA) is in the spotlight ahead of its Q4 earnings, with Evercore ISI and Piper Sandler sticking to their ...

The Trump administration's federal mass job cuts may amount to the largest in history. That has financial ramifications for ...